<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122632">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01824472</url>
  </required_header>
  <id_info>
    <org_study_id>814153</org_study_id>
    <secondary_id>R34HL109462</secondary_id>
    <nct_id>NCT01824472</nct_id>
  </id_info>
  <brief_title>Understanding the Sleep Apnea/Insomnia Interaction</brief_title>
  <official_title>Understanding the Sleep Apnea/Insomnia Interaction: a CPAP/Sham-CPAP Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States:  University of Pennsylvania IRB#3</authority>
    <authority>United States:  University of Pennsylvania Office of Human Research</authority>
    <authority>United States:  University of Pennsyvlania Clinical and Translational Research Center</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly half of all patients with obstructive sleep apnea have insomnia symptoms, and in
      some, but not all cases, these insomnia symptoms are caused by the obstructive sleep apnea.
      The purpose of this study is to find out what type of insomnia symptoms are caused by
      obstructive sleep apnea and therefore most likely to respond to obstructive sleep apnea
      treatment with continuous positive airway pressure (also known as CPAP) and if additional
      treatment with cognitive-behavioral therapy for insomnia is beneficial.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Insomnia Severity Index Score</measure>
    <time_frame>Day 42</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Initiation and Maintenance Disorders</condition>
  <arm_group>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP therapy for sleep apnea and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham CPAP (ineffective CPAP--placebo/sham for sleep apnea) and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP therapy for sleep apnea and cognitive-behavioral therapy for insomnia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Treatment for sleep apnea</description>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <other_name>Continuous positive airway pressure therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT</intervention_name>
    <description>Treatment for insomnia</description>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <other_name>Cognitive-Behavioral Therapy for Insomnia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham CPAP</intervention_name>
    <description>Placebo for sleep apnea</description>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <other_name>Sham (placebo) continuous positive airway pressure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CC</intervention_name>
    <description>Placebo (sham) for insomnia</description>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <other_name>Contact control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sleep Apnea

          2. Insomnia

          3. Age &gt;18

        Exclusion Criteria:

          1. Sedative/psychoactive drug use recently

          2. Other clinically significant sleep disorders

          3. Previous treatment for OSA

          4. Requires oxygen or bilevel PAP therapy

          5. Clinically unstable medical condition

          6. Recent shift work

          7. Significant alcohol use

          8. Other clinically significant causes of insomnia

          9. Illicit drug use

         10. Prescription stimulants

         11. Safety restrictions

         12. Unable to treat sleep apnea with positive airway pressure therapy

         13. Communication barriers

         14. Cognitive impairment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nalaka Gooneratne, MD</last_name>
    <phone>215 349 5948</phone>
    <email>ngoonera@mail.med.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 1, 2013</lastchanged_date>
  <firstreceived_date>April 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Nalaka Gooneratne</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
